Salvage cryotherapy for prostate cancer.
Arch Ital Urol Androl
; 95(4): 11897, 2024 Jan 08.
Article
em En
| MEDLINE
| ID: mdl-38193227
ABSTRACT
BACKGROUND:
Most men diagnosed with prostate cancer will be candidates for active treatment and 20 to 50% of patients treated with organ preserving strategies recur within the prostate. Optimal treatment of recurrence is controversial. Prostate cryosurgery has been increasingly used as primary, recurrence and focal treatment for prostate cancer.METHODS:
We analysed 55 patients submitted to cryotherapy as salvage treatment after recurrence.RESULTS:
Study population presented with a mean age of 70.9 ± 6.2 years, mean initial PSA of 7.6 ng/ml and average prostate volume by ultrasound of 43.2 ± 14.7 grams. Mean follow-up was of 18.0 months. Biochemical free survival at one year of follow-up was of 85%.CONCLUSIONS:
Cryotherapy can be an effective and safe treatment for recurrence after primary curative treatment failure.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Próstata
/
Crioterapia
Limite:
Aged
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Arch Ital Urol Androl
Ano de publicação:
2024
Tipo de documento:
Article